Doris Dee Fleming, NP
Primary Care · Eugene, ORNPI 1386002038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 97 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- Exact Sciences$411
- Novo Nordisk$234
- Lilly USA, LLC$204
- Otsuka America Pharmaceutical, Inc.$161
- Organon$104
- plus $399 from 10 others
What the payments were for
- Food & beverage$1,951100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $438 |
| Exact Sciences | 19 | $411 |
| Novo Nordisk | 14 | $234 |
| Lilly USA, LLC | 12 | $204 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Organon | 4 | $104 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63 |
| Coopersurgical, Inc. | 3 | $59 |
| Pfizer | 2 | $41 |
| Genentech USA, Inc. | 1 | $24 |
| GSK | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $16 |
How this compares
$1,951 in reported general payments places this provider in the 85th percentile of 55 primary care providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 102 | $4,258 |
| Liothyronine Sodium | 60 | $2,195 |
| Np ThyroidThyroid,pork | 20 | $1,111 |
| Levothyroxine Sodium | 129 | $1,049 |
| Testosterone Cypionate | 14 | $540 |
| Estradiol | 45 | $439 |
| Atorvastatin Calcium | 20 | $270 |
| Metformin Hcl ErMetformin Hcl | 20 | $224 |
| Duloxetine Hcl | 11 | $184 |
| Losartan Potassium | 15 | $156 |
| Lisinopril | 22 | $149 |
| Hydrochlorothiazide | 13 | $94 |
| Amlodipine Besylate | 11 | $78 |
| Trazodone Hcl | 13 | $72 |
Paid to pharmacies, not to this prescriber.
Other primary care in Eugene
- Carma DouglasEugene$73
- Rachel SinghEugene$46
- Sarah WestEugene$15
- Lauren DanahyWest Linn$8K
- Leona AndersonGlendale$4K
- Gail PearsonCorvallis$3K
- Tanya FresquezSpringfield$3K
- Christina MartinMedford$2K
- Susan GillispieForest Grove$2K
- Laurie DahlCentral Point$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.